While the world has changed for everyone—and drugmakers expect some financial pain this year—many enjoyed a productive year last year, with sales increases, new drug launches, M&A deals and plenty of clinical data. Those companies, and some with less stellar résumés, rewarded their CEOs handsomely for that work.
Here the list of Top paid CEOs of 2019
(1) Martine Rothblatt
Martine Rothblatt, United Therapeutics
2019 total pay: $45.64 million
2018 total pay: $16.01
Percentage change: 185%
(2) Daniel O’Day
Daniel O’Day, Gilead Sciences
2019 pay: $29.11 million
2018 pay: N/A
Change: N/A
(3) Kenneth Frazier
Kenneth Frazier, Merck & Co.
2019 pay: $27.65 million
2018 pay: $20.93 million
Change: 32%
(4) Alex Gorsky
Alex Gorsky, Johnson & Johnson
2019 total pay: $25.37 million
2018 total pay: $20.1 million
Percentage change: 26.2%
(5) Richard Gonzalez
Richard Gonzalez, AbbVie
2019 total pay: $21.61 million
2018 total pay: $21.28 million
Percentage change: 1.6%
Full Article:- https://www.fiercepharma.com/special-report/top-15-highest-paid-biopharma-ceos-2019